Cel Sci (CVM) Return on Capital Employed [ROCE] (2011 - 2026)
Cel Sci's Return on Capital Employed [ROCE] was -154.21% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 6.88 percentage points from -161.08% a year earlier but down 10.81 percentage points from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Return on Capital Employed [ROCE] at Cel Sci came in at -110.54%, down 1.40 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for three consecutive fiscal years, with a five-year change of -13.33 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Capital Employed [ROCE] was -109.15% in FY2024 (-19.06 pp), -90.09% in FY2023 (-28.47 pp), -61.61% in FY2022 (+5.09 pp) and -66.70% in FY2021 (+30.52 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -161.08% (fiscal Q3 2025) and -49.03% (fiscal Q4 2021) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in two of the last eight quarters, with an average year-over-year change of -6.00 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q1 2022 (a gain of 29.48 percentage points); the worst was fiscal Q4 2023 (a drop of 48.29 percentage points).
- Per Business Quant data, CVM's Return on Capital Employed [ROCE] in the three fiscal quarters before Q3 2026 was -143.40% (Q2 2026), -113.67% (Q1 2026) and -129.79% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.76% |
| 10 | Cel Sci | 3.69 Mn | -21.96 Mn | - | -154.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -154.21% |
| Mar 31, 2026 | -143.40% |
| Dec 31, 2025 | -113.67% |
| Sep 30, 2025 | -129.79% |
| Jun 30, 2025 | -161.08% |
| Mar 31, 2025 | -142.87% |
| Dec 31, 2024 | -128.25% |
| Sep 30, 2024 | -126.00% |
| Jun 30, 2024 | -128.53% |
| Mar 31, 2024 | -120.25% |
| Dec 31, 2023 | -122.46% |
| Sep 30, 2023 | -121.82% |
| Jun 30, 2023 | -109.99% |
| Mar 31, 2023 | -92.87% |
| Dec 31, 2022 | -81.47% |
| Sep 30, 2022 | -73.53% |
| Jun 30, 2022 | -62.98% |
| Mar 31, 2022 | -59.78% |
| Dec 31, 2021 | -52.29% |
| Sep 30, 2021 | -49.03% |
API Access
Cel Sci Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();